Board of Directors
Jonathan M. Niloff, MD, FACOG, FRCS, FACS, FACPEFounder, Chief Medical Officer and Chairman of the Board, MedVentive
Founder, Chief Medical Officer and Chairman of the Board, Dr. Niloff is also an Associate Professor of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School. Prior to joining MedVentive, he served as President of the Beth Israel Deaconess Physicians Organization, Medical Director for Obstetrics and Gynecology for its Affiliated Physicians Group, and Chief of Gynecology at New England Deaconess Hospital. He has deep expertise in all aspects of medical cost and quality improvement, and has published extensively on the topic of gynecologic oncology including the development of the CA125 test for ovarian cancer. He received his undergraduate education at John Hopkins University, an MD degree from McGill University, and an MBA degree from Boston University.
Charles (Charlie) BakerEntrepreneur-in-Residence, General Catalyst Partners
Charlie Baker has spent his career bringing success and strong management to both the private and public sectors in Massachusetts. Mr. Baker is currently Entrepreneur-in-Residence at General Catalyst Partners, a venture capital and growth equity firm. In addition, he serves on the governing boards at The Schwartz Center for Compassionate Healthcare in Boston, HealthView in Danvers, and MedVentive in Waltham. Prior to his current activities, Mr. Baker was CEO of Harvard Pilgrim Health Care. He led a major turnaround at HPHC, which included a $220 million year-to-year improvement in financial performance from 1999 to 2000, and the amicable separation of HPHC and HVMA. Under Mr. Baker's tenure, HPHC went on to become the highest ranked health plan in the country for member satisfaction and clinical effectiveness for five years running, and was named a Boston Business Journal “Best Places To Work” for seven straight years. Before being recruited to lead HPHC, he had an illustrious career in public service that included Secretary of Administration and Finance for four years where he re-structured and simplified the state’s purchasing system, led a major effort to improve the state’s capacity to collect third party revenue, and oversaw the largest effort ever to modernize the state’s code of regulation. He received the Distinguished Service Award from the National Governor’s Association in 1998. Prior to that, he joined the newly elected Weld/Cellucci Administration as Undersecretary for Health in the Executive Office of Health and Human Services. As Undersecretary, Mr. Baker played pivotal roles in Medicaid reform, facility consolidation, and the expansion of a number of key public health programs. He then became Secretary of Health and Human Services in the fall of 1992, and led the Administration’s efforts to enact welfare reform. Mr. Baker received his undergraduate degree from Harvard College and his MBA from Kellogg Graduate School of Management at Northwestern University.
Nancy G. BrownChief Growth Officer, MedVentive
Nancy Brown has more than 25 years of experience in clinical research and automating clinical information systems, combining management, consulting and information technology skills. At MedVentive, she is responsible for leading sales, marketing and business development efforts. Previously, she served as Senior Vice President of Corporate Development of athenahealth and was responsible for identifying opportunities that drive growth and operational improvements. She also held the position of Senior Vice President of Clinical Service Development and spearheaded the creation of athenahealth’s clinical product line. Prior to joining athenahealth in 2004, she was a senior vice president at McKesson Corporation, focused on marketing and strategic planning. She joined McKesson in 1999 when it acquired a company she co-founded, Abaton.com, a provider of internet-based clinical solutions for the ambulatory market. Earlier, she spent eight years at Harvard Community Health Plan where she held several senior management roles. Brown earned a BS at the University of New Hampshire, and an MBA from Northeastern University.
Peter GruaPartner at HLM Venture Partners
Peter Grua’s investment activity has been focused on healthcare services and healthcare information technologies. Prior to joining HLM in 1992, he was a Managing Director of Alex, Brown & Sons, where he directed research in healthcare services and managed care. Previously, he was a research analyst at William Blair & Company and a strategy consultant at Booz Allen Hamilton. He has served or is a director of a number of public companies including: Atria Communities (NASDAQ), Familymeds (NASDAQ), Health Care REIT (NYSE), The Advisory Board Company (NASDAQ), and Renal Care Group (NYSE). He is also currently a director of several private companies including CaseNet, GTESS, Sanovia, Silverlink Communications and Socios Mayores en Salud. He received an AB from Bowdoin College and an MBA from Columbia University.
Nancy J. HamPresident & CEO, MedVentive
Nancy Ham has a proven track record of innovative and high-energy leadership in establishing, developing, growing, and operating both private and public healthcare information technology companies. As President & CEO, she is responsible for the overall performance and strategic direction of the company, as well as managing MedVentive's day-to-day business operations. Most recently, she served as president of Sentillion, Inc., a leading innovator of identity and access management solutions for more than 350,000 caregivers practicing at more than 500 hospitals. Prior to Sentillion, she was president of ProxyMed, Inc., the industry's second-largest independent medical claims clearinghouse with connectivity to more than 450,000 providers, 30,000 pharmacies, 500 laboratories, and more than 1,500 payers. Before ProxyMed, she was responsible for managing more than $50 million in revenue as general manager of institutional and connectivity service Healtheon/WebMD Corporation. Additionally, she served as SVP, Business Development and CFO at ActaMed Corporation and spent five years in leveraged finance at GE Capital. She holds a BA in economics from Duke University and a Masters in International Business Studies (MIBS) from the University of South Carolina.
Victor KatsInvestment Manager at Ascension Health Ventures
Victor Kats joined Ascension Health Ventures (AHV) in 2009 from Allscripts-Misys, a $3 billion healthcare information technology company formed in October 2008 by the merger of Misys Healthcare Systems and Allscripts Healthcare Solutions. Victor is focused on investments in the healthcare technology sector. He brings more than 15 years of leadership experience to AHV, including an extensive background in mergers and acquisitions, corporate and business development, strategy and operations. At Allscripts-Misys, he served as Vice President of Corporate Development after fulfilling a similar role at Misys. Prior to his tenure at Misys, Victor served as a Vice President with Lehman Brothers where he focused on communications, media and technology sectors. He graduated from the University of North Carolina at Chapel Hill and received an MBA from the Wharton School of Business at the University of Pennsylvania.
Mark LevineManaging Director, Core Capital Partners
Mark Levine joined Core Capital in 2000 from GCI Venture Partners, an early stage technology venture capital fund that he founded. GCI Venture Partners was an early investor in webMethods, one of the most successful software IPOs in NASDAQ history. Previously, he served as an officer of GEO-CENTERS, a technology firm with more than $200 million in revenue when it was acquired by SAIC. There, he was responsible for corporate development, government and industry relations, and management of the firm's intellectual property portfolio, licenses and joint ventures. Prior to that, he was Subcommittee Staff Director for the Small Business Committee in the U.S. House of Representatives and was involved in several successful legislative and regulatory initiatives including the Small Business Innovation Development Act and the Small Business and University Patent Act. He received his MBA from George Washington University and lives in Washington, DC with his wife and two children.
Enrico Petrillo, MDManaging Director at Excel Venture Management
Dr. Petrillo has a wealth of experience as a venture investor, healthcare consultant, entrepreneur, and physician that has been instrumental in the success of CB Health Ventures (CBHV), two funds which he co-founded. Dr. Petrillo has been advising and building successful healthcare and IT companies for more than 20 years. He initiated investments in Aileron, US Genomics, BioTrove, Quovadx (now Healthvision), eBenX (acquired by SHPS), and Morphotek (acquired by Eisai). He has been a Director and/or an Observer at GeneOhm (acquired by Becton Dickinson – BDX) , Exact (EXAS) , Aileron Therapeutics, BioTrove, U.S. Genomics, Morphotek, Quovadx, eBenX, TransMedics , and was a founder of Molecular Insight (MIPI). Previously he was a partner at Fletcher Spaght, a Boston-based consulting firm spun out of Boston Consulting Group that specializes in strategy and market consulting for multi-stage medical and IT companies. He is a current advisor to the Department of Defense, Office of the Secretary and affiliated agencies. In addition to being a full time partner at Excel, he is an Adjunct Assistant Professor of Medicine at Boston University. He earned both his undergraduate and MD degrees from Tufts University, and completed his internship and residency at Harvard-affiliated hospitals in Boston.